A Clinical Study of PD-L1 Antibody ZKAB001（Drug Code） in Locally Advanced and Metastatic Urothelial Carcinoma
Clinical trial NCT03676946 · UNKNOWN
Trial details
- NCT number
- NCT03676946
- Sponsor
- Lee's Pharmaceutical Limited
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-10
- Primary completion
- 2020-02-14
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.